Minerva Neurosciences Announces Listing Transfer to Nasdaq Capital Market
09 sept. 2022 16h05 HE
|
Minerva Neurosciences, Inc
BURLINGTON, Mass., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...
BREAKING NOTICE: ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Minerva Neurosciences, Inc. Investors with Large Losses to Secure Counsel Before Important February 8 Deadline – NERV
29 janv. 2021 15h58 HE
|
The Rosen Law Firm PA
NEW YORK, Jan. 29, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Minerva Neurosciences, Inc. (NASDAQ: NERV) between May 15,...
ROSEN, A LEADING LAW FIRM, Reminds Minerva Neurosciences, Inc. Investors of Important February 8 Deadline in Securities Class Action – NERV
18 janv. 2021 17h00 HE
|
The Rosen Law Firm PA
NEW YORK, Jan. 18, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Minerva Neurosciences, Inc. (NASDAQ: NERV) between May 15, 2017...
ROSEN, A LEADING LAW FIRM, Reminds Minerva Neurosciences, Inc. Investors of Important February 8 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – NERV
14 janv. 2021 12h06 HE
|
The Rosen Law Firm PA
NEW YORK, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Minerva Neurosciences, Inc. (NASDAQ: NERV) between May 15, 2017...
ROSEN, A LEADING AND LONGSTANDING FIRM, Reminds Minerva Neurosciences, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – NERV
08 janv. 2021 17h08 HE
|
The Rosen Law Firm PA
NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Minerva Neurosciences, Inc. (NASDAQ: NERV) between May 15, 2017...
ROSEN, A HIGHLY RESPECTED FIRM, Reminds Minerva Neurosciences, Inc. Investors of Important February 8 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – NERV
31 déc. 2020 16h28 HE
|
The Rosen Law Firm PA
NEW YORK, Dec. 31, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Minerva Neurosciences, Inc. (NASDAQ: NERV) between May 15, 2017...